Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 1, 2022
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
Vikram Purohit Maintained (TIL) at Hold with Decreased Target to $120 on, Nov 1st, 2022
Vikram Purohit of Morgan Stanley, Maintained "Instil Bio, Inc." (TIL) at Hold with Decreased Target from $160 to $120 on, Nov 1st, 2022.
Vikram has made no other calls on TIL in the last 4 months.
There is 1 other peer that has a rating on TIL. Out of the 1 peers that are also analyzing TIL, 0 agree with Vikram's Rating of Hold.
This is the rating of the analyst that currently disagrees with Vikram
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $320 on, Tuesday, August 23rd, 2022
